Literature DB >> 31948749

WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1.

Feng Wang1, Jiayi Zhang1, Xiaoxue Ke1, Wen Peng1, Gaichao Zhao1, Shihan Peng1, Jie Xu1, Bo Xu2, Hongjuan Cui3.   

Abstract

The WD repeat domain 5 (WDR5), also known as SWD3 and BIG-3, is often overexpressed in cancers, however its molecular function in cancer remains to be elucidated. In this study, we found that WDR5 promoted the proliferation and self-renewal of glioblastoma and neuroblastoma cells. The data from databases and Western blot assay showed that CARM1 is a downstream gene of WDR5-Myc axis. In addition, we observed that WDR5 promoted the binding of Myc to CARM1 promoter by interacting with Myc and inducing histone 3 lysine 4 trimethylation (H3K4me3). Dual luciferase reporter system indicated that Myc binds to the upstream region (-520 to -515) before transcription start site (TSS) of CARM1 promoter. These findings suggest a novel regulatory model for the proliferation and tumorigenesis of glioblastoma and neuroblastoma by WDR5-Myc axis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CARM1; Glioblastoma and neuroblastoma; Proliferation; WDR5-Myc axis

Year:  2020        PMID: 31948749     DOI: 10.1016/j.bbrc.2019.12.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Bivalent Regulation and Related Mechanisms of H3K4/27/9me3 in Stem Cells.

Authors:  Han Sun; Yin Wang; Ying Wang; Feng Ji; An Wang; Ming Yang; Xu He; Lisha Li
Journal:  Stem Cell Rev Rep       Date:  2021-08-21       Impact factor: 5.739

2.  Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma.

Authors:  Qi-Lei Han; Xiang-Lei Zhang; Peng-Xuan Ren; Liang-He Mei; Wei-Hong Lin; Lin Wang; Yu Cao; Kai Li; Fang Bai
Journal:  Acta Pharmacol Sin       Date:  2022-10-07       Impact factor: 7.169

3.  Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site.

Authors:  Ali Imran; Brandon S Moyer; Dan Kalina; Thomas M Duncan; Kelsey J Moody; Aaron J Wolfe; Michael S Cosgrove; Liviu Movileanu
Journal:  ACS Chem Biol       Date:  2022-05-25       Impact factor: 4.634

Review 4.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

5.  Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.

Authors:  Ali Imran; Brandon S Moyer; Ashley J Canning; Dan Kalina; Thomas M Duncan; Kelsey J Moody; Aaron J Wolfe; Michael S Cosgrove; Liviu Movileanu
Journal:  Biochem J       Date:  2021-06-11       Impact factor: 3.766

Review 6.  Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.

Authors:  Jean-Paul Bryant; John Heiss; Yeshavanth Kumar Banasavadi-Siddegowda
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

7.  Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker.

Authors:  Yingqi Qiu; Hao Wang; Peiyun Liao; Binyan Xu; Rong Hu; Yulu Yang; Yuhua Li
Journal:  BMC Genom Data       Date:  2022-01-16

8.  Expression of pluripotency-related genes in human glioblastoma.

Authors:  Álvaro Fabrício Lopes Rios; Daniela Pretti da Cunha Tirapelli; Mucio Luiz de Assis Cirino; Andressa Romualdo Rodrigues; Ester S Ramos; Carlos Gilberto Carlotti
Journal:  Neurooncol Adv       Date:  2021-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.